News

Investors Take Action Against SelectQuote Amid Legal Concerns

Investors Take Action Against SelectQuote Amid Legal Concerns

Legal Challenges Facing SelectQuote

Recent events have spurred a securities class-action lawsuit against SelectQuote, Inc. (NASDAQ: SLQT) following the intervention of the U.S. Department of Justice (DOJ) in a related lawsuit. This unforeseen development led to a significant drop of 19% in SelectQuote's stock price on May 1, 2025, causing considerable financial setbacks for investors.

Details of the Lawsuit

The case, known as Pahlkotter v. SelectQuote, Inc. et al., represents a group of investors who acquired SelectQuote securities between September 9, 2020, and May 1, 2025. This class action aims to hold accountable those responsible for misrepresenting essential information about the company’s operations.

Class Period Defined

Investors are encouraged to participate in this legal action and can submit their losses before the lead plaintiff deadline, which falls on October 10, 2025.

Core Allegations Against SelectQuote

The crux of the complaint suggests that SelectQuote misled shareholders by not revealing critical aspects of its business practices, especially in relation to Medicare Advantage (MA) sales. Despite claims of offering impartial guidance and comparisons for MA plans, the lawsuit contends the company engaged in practices that favored certain insurance providers based on financial gains rather than consumer welfare.

Specific Claims of Impropriety

The allegations further assert that SelectQuote:

1. Directed Medicare beneficiaries to specific plans based on commissions rather than the best interest of the clients.

2. Accepted unlawful kickbacks for promoting certain plans.

3. Disregarded federal regulations, including violations of the False Claims Act.

Impact of DOJ's Intervention

The claims highlighted in the lawsuit are supported by the DOJ's findings, which argue that from 2016 to at least 2021, SelectQuote received substantial illegal kickbacks, totalling tens of millions of dollars.

Additionally, the DOJ revealed instances where SelectQuote minimized support for less profitable beneficiaries while directing clients solely to the most lucrative plans.

Stock Market Repercussions

The stock's value has plummeted by over 40% within the past six months, vividly illustrating how legal troubles can deeply affect company appraisal. This downturn echoes investors' concerns and the erosion of trust in SelectQuote.

Investigation by Hagens Berman

The legal firm Hagens Berman is ambitiously investigating whether SelectQuote artificially inflated its revenues through alleged misleading techniques. The firm is assessing whether the marketed 'unbiased' service model was merely a facade concealing unethical practices behind the scenes.

Statements from Hagens Berman

Reed Kathrein, a leading partner at Hagens Berman, stated that the DOJ's involvement marks a crucial turning point in understanding SelectQuote's operations. "This scrutiny unveils the extent of corporate misrepresentation," Kathrein noted, emphasizing that such revelations have consequential effects on public trust and investor confidence.

Looking for More Information?

Investors who have suffered substantial losses, or those possessing information pertinent to the investigation, are urged to come forward. Hagens Berman is keen on uncovering the facts surrounding these allegations and addressing the needs of affected investors.

Frequently Asked Questions

What is the lawsuit about?

The lawsuit addresses SelectQuote's alleged misrepresentation of its business practices concerning Medicare Advantage sales and unethical conduct related to financial incentives.

How has the DOJ's involvement affected SelectQuote?

The DOJ's intervention has raised serious concerns about SelectQuote's business practices, leading to a steep decline in stock value and sparking investor lawsuits.

What is Hagens Berman's role in this situation?

Hagens Berman is investigating SelectQuote's actions, assessing whether its revenues were artificially inflated due to misleading practices.

What should investors do if they've suffered losses?

Affected investors are encouraged to submit their claims with Hagens Berman and participate in the ongoing legal proceedings.

Where can I find further information on the case?

Additional details and updates on the case can be obtained by contacting Hagens Berman directly or visiting their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Scribd’s First Safety Report Shows Enforcement at Scale

Updated Category News Views 85

Forty-seven million enforcement actions is not a decorative statistic Scribd finally put some hard numbers on a problem most document platforms prefer to discuss in foggy corporate language. Its first transparency report, covering January through June 2026, says the company took more than 47 million moderation actions across Scribd and Slideshare. That is a hulking...

Continue Reading
SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 65

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 38

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 30

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
VeriSilicon's New AI/AR Glasses Tech: Game-Changer?

Updated Category News Views 34

VeriSilicon Unveils Next-Generation Subsystem There's some sizzle in the air with VeriSilicon's latest move in the wearable tech arena. They’ve launched a low-power, high-performance subsystem aimed squarely at AI and augmented reality glasses. Now, these gizmos aren't just the stuff of science fiction. Thanks to their Nano-XR series, reality might just get a splash...

Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 68

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 105

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading
Max y Noelia Explore Trade at 9th CIIE in Shanghai

Updated Category News Views 23

Influencers at the Heart of Global Trade Exploration Makin' their debut on the big stage of the 9th China International Import Expo (CIIE), Mexican influencers Max y Noelia found themselves caught in a whirlwind of trade and cultural exchanges over in Shanghai. These digital mavens aren't just snapping selfies. Nope, they're capturing the very essence of international...

Continue Reading
RBI Prices $1 Billion of Secured Notes Due 2031, 2036

Updated Category News Views 189

A billion dollars of fresh paper just landed on Restaurant Brands International’s balance-sheet doorstep, and this one deserves more than the usual sleepy glance at a financing release. RBI has priced $500 million of 6.00% senior secured notes due 2031 and another $500 million of 6.40% senior secured notes due 2036. The expected closing date is November 24, 2026,...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 67

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading

Top 5 Most Recently Viewed Articles

Rogers 5G Network Achieves Top Reliability Rankings in Canada

Updated Category News Views 293

Rogers Communications Recognition for 5G Reliability Rogers Communications has recently achieved a significant milestone, being recognized as the most reliable 5G wireless network in the country. This recognition comes from umlaut, a respected global leader in independent benchmarking. With this award, Rogers reaffirms its commitment to providing exceptional network...

Continue Reading
Cable Insurance Partners with TruckerCloud for Telematics Growth

Updated Category News Views 179

Cable Insurance Partners with TruckerCloud for Telematics Growth Cable Insurance, known for its commitment to commercial auto insurance, has formed a strategic alliance with TruckerCloud, a prominent telematics provider. This partnership is set to revolutionize Cable's telematics efforts, focusing on integrating real-time driving insights, streamlining claims processes,...

Continue Reading
Osisko Development Secures $24.2 Million in Funding via Placement

Updated Category News Views 256

Osisko Development’s Major Funding Achievement Osisko Development Corp. is thrilled to report the successful completion of the first tranche of its non-brokered private placement. This strategic move has garnered approximately US$24.2 million through the issuance of 13,426,589 units at a price of US$1.80 per unit. These funds mark a significant advancement for the...

Continue Reading
Anywhere Real Estate Inc. Celebrates 14 Years of Ethics in Business

Updated Category News Views 167

Anywhere Real Estate Inc. Recognized for Ethical Leadership Anywhere Real Estate Inc. (NYSE: HOUS), a leader in residential real estate services, proudly announced its recognition as one of the 2025 World’s Most Ethical Companies for the 14th consecutive year. This accolade highlights the company’s unwavering commitment to ethical practices, setting it apart in an...

Continue Reading
Stifel Affirms Buy Rating for STAAR Surgical Amid Market Challenges

Updated Category News Views 78

Stifel Affirms Strong Support for STAAR Surgical Recently, Stifel renewed its Buy rating for STAAR Surgical (NASDAQ:STAA), setting a target price of $44.00 per share. This upbeat assessment comes even amid broader market challenges. By analyzing various data points from China's refractive sector, Stifel suggests that the second half of 2024 could show signs of recovery...

Continue Reading